skip to primary navigationskip to content

Owlstone Medical Opens New Breath Biopsy Lab

last modified Mar 23, 2017 08:59 AM
Tony Blair officially opened the new high volume lab in Cambridge last week

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the company’s new high volume clinical laboratory.

During the visit, Mr Blair learned more about the company’s Breath Biopsy® technology and its mission to save 100,000 lives and $1.5 billion in healthcare costs. He was also given a tour of Owlstone Medical headquarters including the new clinical lab and other research facilities.

The opening of a new clinical lab with increased capacity enables Owlstone Medical to offer high quality and high throughput Biomarker Services to academics, clinicians, pharmaceutical companies and CROs to identify novel breath biomarkers for disease diagnostics as well as precision medicine applications including therapeutic response, patient stratification and outcome prediction.

The clinical lab also provides VOC biomarker analysis of breath samples and other biospecimens from the on-going clinical trials in Owlstone Medical’s own clinical pipeline: early detection of lung cancer (LuCID), colorectal cancer (InTERCEPT) and treatment stratification in asthma (STRATA).

Billy Boyle, co-founder and CEO at Owlstone Medical commented: “Our new high volume clinical lab follows the successful commercial launch of our Biomarker Services earlier this year and the announcement of our first clinical and pharma customers. Having a state-of-the-art and globally unique capability allows us to increase capacity to handle large service projects as well as support our ongoing clinical trials.”

Tony Blair said: “I congratulate Owlstone Medical on the opening of its new clinical lab. It was a pleasure to meet the dedicated staff of this successful, dynamic company, united in their clear vision to save lives. The breath biopsy technology has huge potential to lead to great improvements in healthcare, and I wish the team every success in developing a company that will become a leader in next generation diagnostics.”

Mr Blair also visited ideaSpace West to meet some other Cambridge founders.

To find out more about Owlstone Medical visit: www.owlstonemedical.com

RSS Feed Latest news

Conferences: Get the Most Out of Your Trade Show Experience

Jul 31, 2019

Exhibiting at a conference can be an extremely effective way to meet with potential customers and generate leads, as well as build your start-ups brand presence and create a buzz. But they can be expensive and if not planned well, can waste your small company’s limited resources. Advanced and strategic planning is key to making the most of the experience. So we asked two of our founders, Vaughan Wittorff, Co-Founder & Chief Commercial Officer at PetaGene, and John Pettigrew, Founder and CEO of We Are Futureproofs, for their thoughts on how to approach an exhibition.

Celebrating World Environment Day - Polysolar’s Contribution to Saving our Planet

Jun 05, 2019

ideaSpace exists to support founders with scalable innovative ideas which could potentially address global threats like climate change. To celebrate World Environment Day we spoke to Hamish Watson, founder of ideaSpace alumni company Polysolar – a leader in the provision of solar PV glass for energy generation in buildings. He took us through Polysolar’s story, from product inception to where it is today, and shared his thoughts on the secret to the company’s success, the challenges that have shaped its growth, and some advice on crowdfunding.

View all news